Inventor · disambiguated record
Matthias Rueth
Also filed as: RUETH MATTHIAS
16 granted patents·9 pending applications·130 citations·filing 2004–2022
91Inventor score
Top patents by PatentIndex Score
25 records- 0197US9695233B2Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseasesROCHE GLYCART AG·Filed 2013·Granted Jul 4, 2017·44 cites·11 claims
- 0295US7462639B2Aminopyrazole derivativesHOFFMANN LA ROCHE·Filed 2006·Granted Dec 9, 2008·46 cites·17 claims
- 0391US10683345B2Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseasesROCHE GLYCART AG·Filed 2017·Granted Jun 16, 2020·5 cites·16 claims
- 0490US11091541B2Human FcRn-binding modified antibodies and methods of useHOFFMANN LA ROCHE·Filed 2015·Granted Aug 17, 2021·6 cites·7 claims
- 0584US7501410B2Methods of inhibiting BTK and SYK protein kinasesROCHE PALO ALTO LLC·Filed 2007·Granted Mar 10, 2009·7 cites·1 claims
- 0682US7235574B2Pentafluorosulfanyl compoundsHOFFMANN LA ROCHE·Filed 2005·Granted Jun 26, 2007·6 cites·15 claims
- 0782US7226923B2Phthalazinone derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Jun 5, 2007·8 cites·49 claims
- 0880US2023212277A1Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseasesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 0977US7405231B2Oxidized thioether derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Jul 29, 2008·2 cites·18 claims
- 1069US2021095013A1Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseasesROCHE GLYCART AG·Filed 2020·Application pending·0 cites
- 1168US7247649B2Oxazoles, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2004·Granted Jul 24, 2007·3 cites·5 claims
- 1262US7205325B2Oxazole derivativesHOFFMANN LA ROCHE·Filed 2004·Granted Apr 17, 2007·1 cites·14 claims
- 1359US7259262B2Arylazole derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2004·Granted Aug 21, 2007·1 cites·18 claims
- 1459US7205326B2Aniline derivatives, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2004·Granted Apr 17, 2007·1 cites·25 claims
- 1551US7285569B2Tricycles, their manufacture and use as pharmaceutical agentsHOFFMANN LA ROCHE·Filed 2005·Granted Oct 23, 2007·0 cites·11 claims
- 1648US7342030B2Indole derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Mar 11, 2008·0 cites·16 claims
- 1746US2009221599A1Phthalazinone pyrazole derivatives, their manufacture and use as pharmaceutical agentsBOYD EDWARD·Filed 2007·Application pending·0 cites
- 1844US7749994B2Pentacyclic kinase inhibitorsGENENTECH INC·Filed 2006·Granted Jul 6, 2010·0 cites·17 claims
- 1944US2009143375A1Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical AgentsHOFFMANN LA ROCHE·Filed 2006·Application pending·0 cites
- 2043US2014051834A1Incretin Receptor Ligand Polypeptide Fc-Region Fusion Polypeptides And Conjugates With Altered Fc-Effector FunctionHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2141US7179812B2Diazine derivativesHOFFMANN LA ROCHE·Filed 2005·Granted Feb 20, 2007·0 cites·13 claims
- 2238US2016151487A1Fcrn-binding abolished anti-igf-1r antibodies and their use in the treatment of vascular eye diseasesHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2338US2009291968A1Substituted indazole derivatives, their manufacture and use as pharmaceutical agentsGEORGES GUY·Filed 2007·Application pending·0 cites
- 2438US2006142247A1Tricyclic heterocyclesGEORGES GUY·Filed 2005·Application pending·0 cites
- 2537US2006235013A1Tricyclic azole derivativesGEORGES GUY·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Rueth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →